Alex

Valaris Takes Delivery of Newbuild Drillships VALARIS DS-13 and DS-14

HAMILTON, Bermuda--(BUSINESS WIRE)--Valaris Limited (NYSE: VAL) (“Valaris” or the “Company”) announced today that it has…

New Passive Funds tracking Nifty Indices launched in Japan and Korea

7 new Passive Funds launched in 2023 MUMBAI, India--(BUSINESS WIRE)--#AUM--In the calendar year 2023, seven…

JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration

HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced…

JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology

New collaboration aims to create innovative oligonucleotide therapeutics that enable target delivery to certain tissues…

Alcoa appoints Matt Reed as EVP and Chief Operations Officer

PITTSBURGH--(BUSINESS WIRE)--Alcoa Corporation (NYSE: AA) today announced that it has appointed Matt Reed as Alcoa’s…

BeiGene to Present at the 42nd Annual J.P. Morgan Healthcare Conference

BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$BGNE #BeiGene--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE:…

Almirall Initiates First Phase I Clinical Study of ALM223, an Interleukin 2 Mutant Fusion Protein for Autoimmune Diseases

The phase I study will evaluate the safety, pharmacokinetics, immunogenicity, and pharmacodynamics of ALM223 ALM223…

‘A Working Lunch with Nordin’ Series by the Malaysia Global Business Forum Is Back in Business

KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--#AWorkingLunchWithNordin--Hosted by the Malaysia Global Business Forum (MGBF), ‘A Working Lunch with…